Aurobindo Pharma has informed that the Company has received the letters from the shareholders, named, Roop Chand Bansal, Ashok Sangappa, Vinod Kumar Bajaj, and Umesh Kumar Sushma, informing about the loss of share certificates and also requested for issue of duplicate share certificates. KFin Technologies, Registrar and Share Transfer Agents of the Company has recorded the stop transfer against the aforesaid shares and the Company has processing their requests for issue of duplicate share certificates.
The above information is a part of company's filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1664.00 |
| Dr. Reddys Lab | 1224.70 |
| Cipla | 1234.50 |
| Zydus Lifesciences | 929.35 |
| Lupin | 2311.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: